Have to agree with your critics this time Gan_Gans. You need to qualify your criticism. You've suggested ambiguity by being a bit ambiguous yourself. That doesn't really qualify as evidence. If you have some genuine constructive insights as to where the data or assertions are at all flawed then it serves purpose for shorts and longs alike..
Look forward to your constructive and insightful criticisms so we can avail ourselves of your knowledge. I am not being smart. Counter objective arguments are always worthwhile for all.
Ann: Mesoblast Healthcare Conference Investor Presentation, page-35
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |